|
|
Volumn 10, Issue 2, 2011, Pages 86-
|
|
Regulatory watch: FDA guidance on co-developing investigational drugs
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;
MSC 1936369B;
PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;
SAR 245409;
UNCLASSIFIED DRUG;
XL 147;
CLINICAL TRIAL (TOPIC);
DRUG APPROVAL;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SHORT SURVEY;
ANIMALS;
DRUG APPROVAL;
DRUG DISCOVERY;
DRUGS, INVESTIGATIONAL;
HUMANS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 79551599626
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3363 Document Type: Short Survey |
|
Times cited : (4)
|
|
References (1)
|
